These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 12605313

  • 1. Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies.
    Sairam S, Baethge BA, McNearney T.
    Clin Rheumatol; 2003 Feb; 22(1):24-9. PubMed ID: 12605313
    [Abstract] [Full Text] [Related]

  • 2. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus.
    Escalante A, Brey RL, Mitchell BD, Dreiner U.
    Am J Med; 1995 Jun; 98(6):559-65. PubMed ID: 7778571
    [Abstract] [Full Text] [Related]

  • 3. Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis.
    Shinzato MM, Bueno C, Trindade Viana VS, Borba EF, Gonçalves CR, Bonfá E.
    Lupus; 2005 Jun; 14(12):953-8. PubMed ID: 16425575
    [Abstract] [Full Text] [Related]

  • 4. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A.
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [Abstract] [Full Text] [Related]

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 6. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 7. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
    Rodriguez VE, Gonzalez-Pares EN, Rivera C.
    P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
    [Abstract] [Full Text] [Related]

  • 8. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus.
    López-Longo FJ, Monteagudo I, González CM, Moreno AC, Rodríguez Mahou M, Grau R, Carreño L.
    J Rheumatol; 1998 Sep; 25(9):1743-9. PubMed ID: 9733455
    [Abstract] [Full Text] [Related]

  • 9. Anticardiolipin antibodies in pediatric systemic lupus erythematosus.
    Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A.
    Arch Pediatr Adolesc Med; 1994 Apr; 148(4):398-402. PubMed ID: 8148941
    [Abstract] [Full Text] [Related]

  • 10. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS, Cho ML, Joo YS, Kim WU, Hong YS, Min JK, Lee SH, Park SH, Cho CS, Kim HY.
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [Abstract] [Full Text] [Related]

  • 11. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A, Ruiz-Irastorza G, Egurbide MV, Garmendia M, Gabriel Erdozain J, Villar I, Aguirre C.
    Lupus; 2007 Mar; 16(10):810-6. PubMed ID: 17895304
    [Abstract] [Full Text] [Related]

  • 12. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.
    Sebastiani GD, Galeazzi M, Tincani A, Piette JC, Font J, Allegri F, Mathieu A, Smolen J, de Ramon Garrido E, Fernandez-Nebro A, Jedryka-Goral A, Papasteriades C, Morozzi G, Bellisai F, De Pitá O, Marcolongo R.
    Scand J Rheumatol; 1999 Mar; 28(6):344-51. PubMed ID: 10665739
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J, Musiał J, Jankowski M, Grzywacz M, Szczeklik A.
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion.
    Lopez LR, Santos ME, Espinoza LR, La Rosa FG.
    Am J Clin Pathol; 1992 Oct; 98(4):449-54. PubMed ID: 1415024
    [Abstract] [Full Text] [Related]

  • 15. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J, Suehisa E, Kuratsune H, Machii T, Koike T, Kitani T, Kanakura Y, Amino N.
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [Abstract] [Full Text] [Related]

  • 16. IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events.
    Locht H, Wiik A.
    Clin Rheumatol; 2006 Mar; 25(2):246-50. PubMed ID: 16177835
    [Abstract] [Full Text] [Related]

  • 17. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C, Rauch J, Kassis J, Chang ER, Joseph L, Le Comte M, Fortin PR.
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [Abstract] [Full Text] [Related]

  • 18. [The relationship between elevated antiphospholipid antibodies and thrombosis in hospitalized patients].
    Shi XM, Gong Y, Hu XD, Zhai L.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Sep 06; 55(9):1100-1104. PubMed ID: 34619928
    [Abstract] [Full Text] [Related]

  • 19. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T, Julkunen H, Vaarala O, Leirisalo-Repo M, Stephansson E, Vahtera E, Palosuo T, Myllylä G.
    Blood Coagul Fibrinolysis; 1992 Aug 06; 3(4):407-14. PubMed ID: 1420816
    [Abstract] [Full Text] [Related]

  • 20. The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies.
    Hudson M, Herr AL, Rauch J, Neville C, Chang E, Ibrahim R, Séguin C, Kassis J, Busque L, Fortin PR.
    J Rheumatol; 2003 Nov 06; 30(11):2385-91. PubMed ID: 14677182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.